Quarterly report pursuant to Section 13 or 15(d)

Composition of Certain Financial Statement Captions (Tables)

v3.19.2
Composition of Certain Financial Statement Captions (Tables)
6 Months Ended
Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Composition of Certain Financial Statement Captions
(In thousands)
June 30,
2019
 
December 31,
2018
Accounts receivable, net:
 
 
 
Accounts receivable
$
150,414

 
$
145,665

Less: allowance for doubtful accounts
(2,127
)
 
(1,758
)
 
$
148,287

 
$
143,907

Inventories, net:
 
 
 
Consumable supplies
$
22,008

 
$
23,264

Finished products
21,481

 
15,259

Work in-process
3,096

 
2,473

Raw materials
4,741

 
4,259

Less: inventory reserve
(3,033
)
 
(2,956
)
 
$
48,293

 
$
42,299

Other current assets and prepaid expenses:
 
 
 
Taxes recoverable
18,176

 
15,708

Other receivables
661

 
2,368

Prepaid supplies
10,584

 
9,693

Prepaid insurance
3,878

 
3,436

Other
3,234

 
3,847

 
$
36,533

 
$
35,052

Intangible assets, net:
 
 
 
Customer relationships
$
446,144

 
$
446,296

Technologies
340,702

 
340,729

Trade names
50,420

 
50,404

Licenses
5,766

 
5,766

Covenants not to compete
16,321

 
16,322

Product registrations
8,016

 
7,861

Other
5,586

 
5,613

Less: accumulated amortization
(291,649
)
 
(258,539
)
 
$
581,306

 
$
614,452

Accrued expenses:
 
 
 
Contract liabilities
$
50,388

 
$
63,503

Employee benefits
39,453

 
45,621

Clinical trials
9,936

 
10,401

Contingent consideration
5,387

 
2,375

Finance leases short-term
3,031

 
3,280

Milestone payment
4,968

 
4,871

Professional fees
3,317

 
7,935

Other
81,902

 
65,527

 
$
198,382

 
$
203,513

 
 
 
 

(In thousands)
June 30,
2019
 
December 31,
2018
Other long-term liabilities:
 
 
 
Contract liabilities
$
3,665

 
$
27,566

Line of credit
65,112

 
105,198

Contingent consideration
20,181

 
22,162

Mortgages and other debts payable
4,500

 
4,654

Finance leases long-term
4,650

 
5,620

Other
29,643

 
33,768

 
$
127,751

 
$
198,968


Changes in Goodwill
The following table summarizes the changes in Goodwill during the six months ended June 30, 2019.
 
2019
(In thousands)
Balance at January 1
 
Foreign exchange and other
 
Balance at June 30th
Pharmaceuticals
 
 
 
 
 
CURNA
$
4,827

 
$

 
$
4,827

EirGen
85,245

 
(551
)
 
84,694

FineTech

 

 

OPKO Chile
4,614

 
112

 
4,726

OPKO Biologics
139,784

 

 
139,784

OPKO Health Europe
7,545

 
(49
)
 
7,496

OPKO Renal
2,069

 

 
2,069

Transition Therapeutics
3,323

 
137

 
3,460

 
 
 
 
 
 
Diagnostics
 
 
 
 
 
BioReference
401,821

 

 
401,821

OPKO Diagnostics
17,977

 

 
17,977

OPKO Lab
32,988

 

 
32,988

 
$
700,193

 
$
(351
)
 
$
699,842